Clinical studies recruiting near Oklahoma City

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Phase 3 · Joseph Broderick, MD · NCT07227246 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Hightower Clinical, LLC ( Site 0085) · Merck Sharp & Dohme LLC · NCT06393374 MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · University of Oklahoma Health Sciences Center · National Cancer Institute (NCI) · NCT05564390 A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) G
Phase 1/Phase 2 · University of Oklahoma Health Sciences Center · National Cancer Institute (NCI) · NCT05099003 Study of XB010 in Subjects With Solid Tumors
Phase 1 · Stephenson Cancer Center · Exelixis · NCT06545331 Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed
Phase 3 · University of Oklahoma Health Sciences Center · National Cancer Institute (NCI) · NCT06172296 A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Phase 3 · Hightower Clinical · Kallyope Inc. · NCT07674654 Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · University of Oklahoma Health Sciences Center · NRG Oncology · NCT05624996 Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated C
Phase 3 · University of Oklahoma Health Sciences Center · Alliance for Clinical Trials in Oncology · NCT07321652 A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Phase 2 · University of Oklahoma Health Sciences Center · Children's Oncology Group · NCT06368817 A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · University of Oklahoma Health Sciences Center · National Cancer Institute (NCI) · NCT05691478 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Amgen · NCT07037433 Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astr
Phase 1 · University of Oklahoma Health Sciences Center · National Cancer Institute (NCI) · NCT06860594 PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Viru
Phase 2 · OU Health Physicians - Infectious Disease Clinic · Pulmotect, Inc. · NCT06665100 Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
NA · Mercy Hospital Oklahoma City · Alliance for Clinical Trials in Oncology · NCT07091617 A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
Phase 3 · INTEGRIS Cancer Institute of Oklahoma · argenx · NCT06544499 A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
Phase 3 · Merz Therapeutics GmbH · NCT07018700 MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Phase N/A · Agendia · NCT03053193 SELUTION4BTK Trial
NA · Hightower Clinical Research · M.A. Med Alliance S.A. · NCT05055297 A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Phase 2 · University of Oklahoma Health Sciences Center · Children's Oncology Group · NCT04322318 A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathie
Phase 3 · RAO Research LLC · Pfizer · NCT05895786 Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Phase 3 · University of Oklahoma Health Sciences Center · NRG Oncology · NCT05946213 Nectero EAST System Clinical Study
Phase 2/Phase 3 · Nectero Medical, Inc. · NCT06001918 Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patient
Phase 2 · University of Oklahoma Health Sciences Center · NRG Oncology · NCT06532279 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · University of Oklahoma Health Sciences Center · NRG Oncology · NCT05174169 Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Phase 3 · Eli Lilly and Company · NCT07353931 Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Canc
Phase 3 · University of Oklahoma Health Sciences Center · Alliance for Clinical Trials in Oncology · NCT06632327 Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastati
Phase 3 · University of Oklahoma Health Sciences Center · Alliance for Clinical Trials in Oncology · NCT06931340 Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Ca
Phase 3 · Lynn Health Science Institute · Amgen · NCT07575399 A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Phase 3 · University of Oklahoma Health Sciences Center · Eli Lilly and Company · NCT06672549

Look up another city

Look up another condition